| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50172-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75904SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12000-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52704-0.025mg | |||
![Immunocytochemistry/Immunofluorescence: gamma Catenin [p Tyr550] Antibody [NBP3-23198] - Immunocytochemical labeling of phosphorylated gamma Catenin in control (Top) and pervanadate-treated (Bottom) A431 cells. The cells were co-labeled with mouse monoclonal gamma Catenin (CM1111) or rabbit polyclonal gamma Catenin (Tyr-550) antibodies, then the antibodies were detected using appropriate secondary antibodies conjugated to Cy2 or Cy3.](http://images.novusbio.com/fullsize/nbp3-23198_rabbit-gamma-catenin-p-tyr550-pab-199202312403722.jpg "Immunocytochemistry/Immunofluorescence: gamma Catenin [p Tyr550] Antibody [NBP3-23198] - Immunocytochemical labeling of phosphorylated gamma Catenin in control (Top) and pervanadate-treated (Bottom) A431 cells. The cells were co-labeled with mouse monoclonal gamma Catenin (CM1111) or rabbit polyclonal gamma Catenin (Tyr-550) antibodies, then the antibodies were detected using appropriate secondary antibodies conjugated to Cy2 or Cy3.")
![Western Blot: gamma Catenin [p Tyr550] Antibody [NBP3-23198] - Western blot analysis of anti-gamma Catenin (C-terminal) immunoprecipitates from pervanadate-treated A431. The immunoprecipitates were untreated (lanes 1,3,7) or treated with alkaline phosphatase (lanes 2,4,8). The blots were probed with gamma Catenin (a.a. 545-555), gamma Catenin (Tyr-550) or gamma Catenin (C-terminal) antibodies. The anti-gamma Catenin (Tyr-550) was used in the presence of gamma Catenin (Tyr-550) (lane 5) or gamma Catenin (Tyr-644) (lane 6) peptides.](http://images.novusbio.com/fullsize/nbp3-23198_rabbit-gamma-catenin-p-tyr550-pab-19920231410128.jpg)
![Immunocytochemistry/Immunofluorescence: TRPM8 Antibody [NBP3-23239] - Immunocytochemical labeling of TRPM8 in paraformaldehyde fixed and NP-40 permeabilized MCF-7 cells. The cells were labeled with rabbit polyclonal anti-TRPM8 (NBP3-23239). The antibody was detected using goat anti-rabbit DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23239_rabbit-trpm8-pab-1992023141011.jpg "Immunocytochemistry/Immunofluorescence: TRPM8 Antibody [NBP3-23239] - Immunocytochemical labeling of TRPM8 in paraformaldehyde fixed and NP-40 permeabilized MCF-7 cells. The cells were labeled with rabbit polyclonal anti-TRPM8 (NBP3-23239). The antibody was detected using goat anti-rabbit DyLight(R) 594.")
![Western Blot: TRPM8 Antibody [NBP3-23239] - Western blot image of human TRPM8 in human MDA-MB-231 cells. The blot was probed with rabbit polyclonal anti-TRPM8 (extracellular region) without peptide blocking (lane 1) or with peptide blocking (lane 2).](http://images.novusbio.com/fullsize/nbp3-23239_rabbit-trpm8-pab-1992023191542.jpg)
![Immunocytochemistry/Immunofluorescence: PDK-1 Antibody (M146) [NBP3-23291] - Immunocytochemical labeling of PDK-1 phosphorylation in control and pervanadate-treated A431 cells. The cells were labeled with mouse monoclonal PDK-1 (C-terminal Region) (NBP3-23291), rabbit polyclonal PDK-1 (Tyr-9) (NBP3-23292), and PDK-1 (N-terminus) (NBP3-23290) antibodies. These antibodies were detected using appropriate secondary antibody conjugated to DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23291_mouse-pdk-1-mab-m146-199202318202918.jpg "Immunocytochemistry/Immunofluorescence: PDK-1 Antibody (M146) [NBP3-23291] - Immunocytochemical labeling of PDK-1 phosphorylation in control and pervanadate-treated A431 cells. The cells were labeled with mouse monoclonal PDK-1 (C-terminal Region) (NBP3-23291), rabbit polyclonal PDK-1 (Tyr-9) (NBP3-23292), and PDK-1 (N-terminus) (NBP3-23290) antibodies. These antibodies were detected using appropriate secondary antibody conjugated to DyLight(R) 594.")
![Western Blot: PDK-1 Antibody (M146) [NBP3-23291] - Western blot image of mouse brain (lane 1) and human A431 cells (lane 2). The blot was probed with anti-PDK-1 (C-terminal region) (NBP3-23291).](http://images.novusbio.com/fullsize/nbp3-23291_mouse-pdk-1-mab-m146-199202312523636.jpg)
![Flow Cytometry: Cytokeratin 8/18 Antibody (COU-1) - Chimeric - BSA Free [NBP3-43588] - Paraformaldehyde fixed HeLa cells permeabilized with 0.5% Triton were stained with the anti-unknown specificity antibody (isotype control, black line) or NBP3-43588 (blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor® 488 antibody at a dilution of 1:1000, and the cells were analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-43588_rabbit-cytokeratin-8-18-mab-cou-1-chimeric-azide-bsa-free-flow-cytometry-2220260325810.png "Flow Cytometry: Cytokeratin 8/18 Antibody (COU-1) - Chimeric - BSA Free [NBP3-43588] - Paraformaldehyde fixed HeLa cells permeabilized with 0.5% Triton were stained with the anti-unknown specificity antibody (isotype control, black line) or NBP3-43588 (blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor® 488 antibody at a dilution of 1:1000, and the cells were analyzed using a FACSCanto flow-cytometer.")
![Immunocytochemistry/ Immunofluorescence: Cytokeratin 8/18 Antibody (COU-1) - Chimeric - BSA Free [NBP3-43588] - Immunofluorescence analysis of paraformaldehyde fixed HeLa cells, permeabilized with 0.15% Triton, on coverslips stained with NBP3-43588 (1:100 dilution) for 1h followed by Alexa Fluor® 488 secondary antibody (1:1000 dilution), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, NBP3-43588, DAPI, merged channels, and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor® 488 secondary antibody.](http://images.novusbio.com/fullsize/IMG01553Ab03187-23.0IFfull.png)
![Adhesion Activation: HGF R/c-MET Antibody (8) [NBP2-50172] - Epitope position on molecule](http://images.novusbio.com/fullsize/HGF-R-c-MET-Antibody-8-Adhesion-Activation-NBP2-50172-img0001.jpg "Adhesion Activation: HGF R/c-MET Antibody (8) [NBP2-50172] - Epitope position on molecule")
![Western Blot: MeCP2 Antibody [NBP3-23405] - Western blot of adult mouse brain tissue lysate. The blot lanes were untreated (lanes 1 & 3) or treated with lambda phosphatase (lanes 2 & 4) then probed with rabbit polyclonals anti-MeCP2 (Ser-80) (lanes 1 & 2) or anti-MeCP2 (C-terminus) (lanes 3 & 4).](http://images.novusbio.com/fullsize/nbp3-23405_rabbit-mecp2-pab-19920231410122.jpg "Western Blot: MeCP2 Antibody [NBP3-23405] - Western blot of adult mouse brain tissue lysate. The blot lanes were untreated (lanes 1 & 3) or treated with lambda phosphatase (lanes 2 & 4) then probed with rabbit polyclonals anti-MeCP2 (Ser-80) (lanes 1 & 2) or anti-MeCP2 (C-terminus) (lanes 3 & 4).")
![Immunocytochemistry/Immunofluorescence: MeCP2 Antibody [NBP3-23405] - Immunocytochemical labeling of MeCP2 in rat PC12 cells differentiated with NGF. The cells were probed with MeCP2 (C-terminus) rabbit polyclonal antibody (NBP3-23405) in the absence (left) or presence (right) of blocking peptide. The antibody was detected using appropriate secondary antibody conjugated to DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23405_rabbit-mecp2-pab-1192023166533.jpg)
![Western Blot: EEA1 Antibody (M347) [NBP3-23301] - Western blot of adult mouse brain tissue lysate. The blot was probed with mouse monoclonal anti-EEA1 antibody at 1:500 (lane 1) or 1:1000 (lane 2).](http://images.novusbio.com/fullsize/nbp3-23301_mouse-eea1-mab-m347-19920231856958.jpg "Western Blot: EEA1 Antibody (M347) [NBP3-23301] - Western blot of adult mouse brain tissue lysate. The blot was probed with mouse monoclonal anti-EEA1 antibody at 1:500 (lane 1) or 1:1000 (lane 2).")
![Immunocytochemistry/Immunofluorescence: EEA1 Antibody (M347) [NBP3-23301] - Immunocytochemical labeling of EEA1 in paraformaldehyde-fixed and NP40-permeabilized A7r5 cells. The cells were labeled with mouse monoclonal EEA1 (NBP3-23301). The antibody was detected using goat anti-mouse DyLight(R) 488.](http://images.novusbio.com/fullsize/nbp3-23301_mouse-eea1-mab-m347-19920231856971.jpg)
![Immunocytochemistry/Immunofluorescence: p38 alpha Antibody (M548) [NBP3-23234] - Immunocytochemical labeling of p38 alpha in aldehyde fixed and NP-40 permeabilized human NCI-H446 lung carcinoma cells. The cells were labeled with mouse monoclonal anti-p38 alpha (NBP3-23234). The antibody was detected using goat anti-mouse DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23234_mouse-p38-alpha-mab-m548-199202318202923.jpg "Immunocytochemistry/Immunofluorescence: p38 alpha Antibody (M548) [NBP3-23234] - Immunocytochemical labeling of p38 alpha in aldehyde fixed and NP-40 permeabilized human NCI-H446 lung carcinoma cells. The cells were labeled with mouse monoclonal anti-p38 alpha (NBP3-23234). The antibody was detected using goat anti-mouse DyLight(R) 594.")
![Western Blot: p38 alpha Antibody (M548) [NBP3-23234] - Western blot analysis of human A431 cells (lanes 1 & 2) and rat A7r5 cells (lanes 3 & 4). The blot was probed with mouse monoclonal anti-p38 alpha (C-terminal) clone M548 at a dilution of 1:250 (lanes 1 & 3) or 1:1000 (lanes 2 & 4).](http://images.novusbio.com/fullsize/nbp3-23234_mouse-p38-alpha-mab-m548-19920231856916.jpg)
![Immunohistochemistry: CEACAM5/CD66e Antibody (Arcitumomab) [NBP2-75904] - Formalin fixed human endometrial cancer slices were were stained with a NBP2-75904 at 5 ug/ml.](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-Arcitumomab-Immunohistochemistry-NBP2-75904-img0002.jpg "Immunohistochemistry: CEACAM5/CD66e Antibody (Arcitumomab) [NBP2-75904] - Formalin fixed human endometrial cancer slices were were stained with a NBP2-75904 at 5 ug/ml.")
![Immunocytochemistry /Immunofluorescence: CEACAM5/CD66e Antibody (Arcitumomab) - Azide and BSA Free [NBP2-75904] - Formaldehyde-fixed rat pancreas slices were stained with NBP2-75904 at 5 ug/ml and detected with a FITC-conjugated secondary antibody. NBP2-75904 shows cross-reactivity with rat.](http://images.novusbio.com/fullsize/nbp2-75904_human-monoclonal-ceacam5-cd66e-antibody-arcitumomab-74202522141220.png)
![Western Blot: CCR5 Antibody (RC-10) - Chimeric [NBP3-12000] - Jurkat (A), Molt4 (B), K562 (C) and Daudi (D) cell lysates (35ug protein in RIPA buffer) were resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of RC-10 (NBP3-12000) at 0.0003 ug/ml, 0.001 ug/ml, 0.003 ug/ml and unknown ug/ml, respectively, before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.](http://images.novusbio.com/fullsize/CCR5-Antibody-RC-10-Chimeric-Western-Blot-NBP3-12000-img0001.jpg "Western Blot: CCR5 Antibody (RC-10) - Chimeric [NBP3-12000] - Jurkat (A), Molt4 (B), K562 (C) and Daudi (D) cell lysates (35ug protein in RIPA buffer) were resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of RC-10 (NBP3-12000) at 0.0003 ug/ml, 0.001 ug/ml, 0.003 ug/ml and unknown ug/ml, respectively, before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: CCR5 Antibody (RC-10) - Chimeric [NBP3-12000] - Immunofluorescence analysis of paraformaldehyde fixed U937 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of RC-10 (NBP3-12000) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12000, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CCR5-Antibody-RC-10-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12000-img0002.jpg)
![Flow Cytometry: CCR5 Antibody (RC-10) - Chimeric - Azide and BSA Free [NBP3-12000] - Paraformaldehyde fixed human peripheral blood monocytes permeabilized with 0.5% Triton were stained with anti-unknown specificity antibody (isotype control, black line) or NBP3-12000 (blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-12000_rabbit-monoclonal-ccr5-antibody-rc-10-chimeric-7420252214129.png)
![Immunocytochemistry/Immunofluorescence: EphA2 Antibody (M049) [NBP3-23315] - Immunocytochemical labeling of EphA2 in aldehyde fixed human MDA-MB-231 breast carcinoma cells. The cells were labeled with mouse monoclonal anti-EphA2 (NBP3-23315). The antibody was detected using goat anti-mouse DyLight(R) 594.](http://images.novusbio.com/fullsize/nbp3-23315_mouse-epha2-mab-m049-199202318202917.jpg "Immunocytochemistry/Immunofluorescence: EphA2 Antibody (M049) [NBP3-23315] - Immunocytochemical labeling of EphA2 in aldehyde fixed human MDA-MB-231 breast carcinoma cells. The cells were labeled with mouse monoclonal anti-EphA2 (NBP3-23315). The antibody was detected using goat anti-mouse DyLight(R) 594.")
![Western Blot: EphA2 Antibody (M049) [NBP3-23315] - Western blot of human MDA-MB-231 breast carcinoma (lane 1), A431 epidermoid carcinoma (lane 2), NCI-H2052 epithelioid mesothelioma (lane 3), and A549 lung carcinoma (lane 4). The blot was probed with mouse monoclonal anti-EphA2 (NBP3-23315) at 1:1000.](http://images.novusbio.com/fullsize/nbp3-23315_mouse-epha2-mab-m049-19920231410111.jpg)
![ELISA: EphA2 Antibody (M049) [NBP3-23315] - Representative Standard Curve using mouse monoclonal anti-EphA2 (NBP3-23315) for ELISA capture of human recombinant EphA2 extracellular region with a His-tag. Captured protein was detected by suitable anti-His-tag antibody followed by appropriate secondary antibody HRP conjugate.](http://images.novusbio.com/fullsize/nbp3-23315_mouse-epha2-mab-m049-11920231633166.jpg)